Freedom Investment Management, Inc. - PROTAGONIST THERAPEUTICS INC ownership

PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 65 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Freedom Investment Management, Inc. ownership history of PROTAGONIST THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$212,000
-9.0%
10,867
-17.6%
0.02%
-8.0%
Q2 2020$233,000
+65.2%
13,189
-23.0%
0.02%
+108.3%
Q1 2020$141,000
+18.5%
17,122
+1.0%
0.01%
+20.0%
Q4 2019$119,000
-46.4%
16,947
-8.4%
0.01%
-47.4%
Q3 2019$222,000
-9.4%
18,511
-8.6%
0.02%
-9.5%
Q2 2019$245,000
-5.4%
20,244
-1.7%
0.02%0.0%
Q1 2019$259,000
+46.3%
20,599
-21.8%
0.02%
+50.0%
Q4 2018$177,000
-50.1%
26,335
-29.4%
0.01%
-36.4%
Q3 2018$355,000
+50.4%
37,299
+6.2%
0.02%
+57.1%
Q2 2018$236,00035,1330.01%
Other shareholders
PROTAGONIST THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Pharmstandard International S.A. 750,632$7,724,00026.59%
BVF INC/IL 2,617,967$26,939,0002.37%
GREAT POINT PARTNERS LLC 982,449$10,109,0001.58%
Alambic Investment Management, L.P. 65,128$670,0000.53%
FARALLON CAPITAL MANAGEMENT LLC 2,243,202$23,083,0000.14%
ALGERT GLOBAL LLC 44,477$458,0000.10%
Monashee Investment Management LLC 42,945$442,0000.09%
Tekla Capital Management LLC 219,042$2,254,0000.08%
Spark Investment Management LLC 138,800$1,428,0000.08%
OXFORD ASSET MANAGEMENT LLP 187,653$1,904,0000.04%
View complete list of PROTAGONIST THERAPEUTICS INC shareholders